BET inhibitors drive Natural Killer activation in non-small cell lung cancer via BRD4 and SMAD3.
Reggiani F, Talarico G, Gobbi G, Sauta E, Torricelli F, Manicardi V, Zanetti E, Orecchioni S, Falvo P, Piana S, Lococo F, Paci M, Bertolini F, Ciarrocchi A, Sancisi V.
Reggiani F, et al. Among authors: ciarrocchi a.
Nat Commun. 2024 Mar 22;15(1):2567. doi: 10.1038/s41467-024-46778-8.
Nat Commun. 2024.
PMID: 38519469
Free PMC article.